Tag
#UCB
-
2026
-
UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
-
UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa
-
United Community Banks, Inc. Announces Date for First Quarter 2026 Earnings Release and Conference Call
-
United Community Banks, Inc. Announces Date for First Quarter 2026 Earnings Release and Conference Call
-
UCB – Convening Notice to the General Meeting of the Shareholders 2026
-
United Community Earns 12th JD Power Award in 17 Years, Ranked #1 for Retail Banking Customer Satisfaction in the Southeast Region
-
UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330 Permanent Jobs
-
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common Stock
-
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common Stock
-
United Community Banks, Inc. Reports Fourth Quarter Earnings